Kiran Mianoor
Physician Assistant · Dallas, TXNPI 1134877210
Payments from drug & device makers
Across 278 payments — averaging $27.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- UCB, Inc.$610
- AbbVie$572
- Pfizer$433
- Eisai Inc.$380
- Merz Pharmaceuticals, LLC$317
- plus $3K from 33 others
What the payments were for
- Travel & lodging$85911%
- Food & beverage$6,71488%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 25 | $1,951 |
| UCB, Inc. | 25 | $610 |
| AbbVie | 30 | $572 |
| Pfizer | 29 | $433 |
| Eisai Inc. | 13 | $380 |
| Merz Pharmaceuticals, LLC | 10 | $317 |
| Acadia Pharmaceuticals Inc | 14 | $286 |
| Lilly USA, LLC | 11 | $234 |
| Teva Pharmaceuticals USA, Inc. | 7 | $225 |
| SK Life Science, Inc. | 10 | $208 |
| Jazz Pharmaceuticals Inc. | 7 | $181 |
| Sumitomo Pharma America, Inc. | 10 | $180 |
| Argenx US, Inc. | 5 | $171 |
| Lundbeck LLC | 8 | $161 |
| Octapharma USA, Inc. | 7 | $158 |
| Biogen | 7 | $143 |
| Neurelis, Inc. | 6 | $138 |
| TG Therapeutics, Inc. | 6 | $125 |
| Averitas Pharma Inc. | 1 | $122 |
| Grifols USA, LLC | 5 | $120 |
| Catalyst Pharmaceuticals, Inc. | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $93 |
| Immedica Pharma US, Inc. | 3 | $92 |
| Vanda Pharmaceuticals Inc. | 2 | $78 |
| CSL Behring | 4 | $76 |
| Aucta Pharmaceuticals, Inc. | 5 | $75 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Neurocrine Biosciences, Inc. | 3 | $60 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| GE HealthCare | 2 | $31 |
| Novartis | 1 | $24 |
| NS Pharma, Inc. | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Life Molecular Imaging Ltd | 1 | $20 |
| Tanabe Pharma America, Inc. | 1 | $20 |
| Corium, LLC | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,631 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BriviactBrivaracetam | 67 | $140,428 |
| VimpatLacosamide | 28 | $91,413 |
| AptiomEslicarbazepine Acetate | 20 | $49,149 |
| Lacosamide | 233 | $45,638 |
| QuliptaAtogepant | 28 | $29,808 |
| Qudexy XrTopiramate | 11 | $18,873 |
| NayzilamMidazolam | 24 | $15,580 |
| Lamotrigine ErLamotrigine | 45 | $6,979 |
| Levetiracetam | 190 | $6,977 |
| Clobazam | 97 | $6,758 |
| Oxcarbazepine | 36 | $4,916 |
| Levetiracetam ErLevetiracetam | 65 | $4,761 |
| TegretolCarbamazepine | 12 | $4,668 |
| Zonisamide | 110 | $3,624 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $3,407 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Briviact, Vimpat, Nayzilam | $610 | $247,421119 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $21 | $49,14920 claims |
| AbbVieQulipta | $572 | $29,80828 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Dallas
- Cynthia TrickettDallas$1.3M
- Michael WhiteDallas$276K
- Sofia NeicherilDallas$62K
- Shawn SommerladDallas$53K
- Katherine TurnerDallas$43K
- Tori BurnsDallas$39K
- Suzanne RaczDallas$32K
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.